Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001493152-25-026408
Filing Date
2025-12-05
Accepted
2025-12-05 16:49:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B2 form424b2.htm 424B2 627488
2 GRAPHIC forms-3_001.jpg GRAPHIC 14384
3 GRAPHIC forms-3_002.jpg GRAPHIC 4062
  Complete submission text file 0001493152-25-026408.txt   654345
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-291489 | Film No.: 251553581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)